203 related articles for article (PubMed ID: 34226291)
1. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
[TBL] [Abstract][Full Text] [Related]
2. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
[TBL] [Abstract][Full Text] [Related]
5. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
[TBL] [Abstract][Full Text] [Related]
6. Lymphadenectomy for the management of endometrial cancer.
Frost JA; Webster KE; Bryant A; Morrison J
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007585. PubMed ID: 28968482
[TBL] [Abstract][Full Text] [Related]
7. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy for the management of endometrial cancer.
Frost JA; Webster KE; Bryant A; Morrison J
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007585. PubMed ID: 26387863
[TBL] [Abstract][Full Text] [Related]
9. Systematic lymphadenectomy in early stage endometrial cancer.
Ignatov A; Ivros S; Bozukova M; Papathemelis T; Ortmann O; Eggemann H
Arch Gynecol Obstet; 2020 Jul; 302(1):231-239. PubMed ID: 32430757
[TBL] [Abstract][Full Text] [Related]
10. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
[TBL] [Abstract][Full Text] [Related]
11. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
Obermair A; Nicklin J; Gebski V; Hayes SC; Graves N; Mileshkin L; Lin MY; Beale P; Baxter E; Robledo K; Salomon C; Hanna GB; Janda M
Int J Gynecol Cancer; 2021 Dec; 31(12):1595-1601. PubMed ID: 34728527
[TBL] [Abstract][Full Text] [Related]
12. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
van den Heerik ASVM; Horeweg N; Nout RA; Lutgens LCHW; van der Steen-Banasik EM; Westerveld GH; van den Berg HA; Slot A; Koppe FLA; Kommoss S; Mens JWM; Nowee ME; Bijmolt S; Cibula D; Stam TC; Jurgenliemk-Schulz IM; Snyers A; Hamann M; Zwanenburg AG; Coen VLMA; Vandecasteele K; Gillham C; Chargari C; Verhoeven-Adema KW; Putter H; van den Hout WB; Wortman BG; Nijman HW; Bosse T; Creutzberg CL
Int J Gynecol Cancer; 2020 Dec; 30(12):2002-2007. PubMed ID: 33046573
[TBL] [Abstract][Full Text] [Related]
13. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
Seagle BL; Kocherginsky M; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
[TBL] [Abstract][Full Text] [Related]
14. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis.
Pavone M; Jochum F; Lecointre L; Fanfani F; Scambia G; Querleu D; Akladios C
Int J Gynecol Cancer; 2024 Apr; 34(4):519-527. PubMed ID: 38296516
[TBL] [Abstract][Full Text] [Related]
16. Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: A meta-analysis.
Guo W; Cai J; Li M; Wang H; Shen Y
Medicine (Baltimore); 2018 Jan; 97(1):e9520. PubMed ID: 29505525
[TBL] [Abstract][Full Text] [Related]
17. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
[TBL] [Abstract][Full Text] [Related]
18. Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).
Watari H; Katayama H; Shibata T; Ushijima K; Satoh T; Onda T; Aoki D; Fukuda H; Yaegashi N; Sakuragi N;
Jpn J Clin Oncol; 2017 Oct; 47(10):986-990. PubMed ID: 28981739
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
20. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
